A primer on cytokines

P Chauhan, A Nair, A Patidar, J Dandapat, A Sarkar… - Cytokine, 2021 - Elsevier
Cytokines are pleiotropic polypeptides that control the development of and responses
mediated by immune cells. Cytokine classification predominantly relies on [1] the target …

A historical review of the role of cytokines involved in leishmaniasis

A Mirzaei, M Maleki, E Masoumi, N Maspi - Cytokine, 2021 - Elsevier
Leishmaniasis is an infectious disease caused by the Leishmania genus, affecting millions
of persons in the world. Despite increased studies, no vaccine has been developed against …

Cytokines and signaling networks regulating disease outcomes in leishmaniasis

A Saha, S Roy, A Ukil - Infection and Immunity, 2022 - Am Soc Microbiol
Cytokines play crucial roles in commencing and coordinating the organized recruitment and
activation of immune cells during infection. These molecular regulators play an important …

Cytokines in leishmaniasis: a complex network of stimulatory and inhibitory interactions

C Bogdan, A Gessner, M Röllinghoff - Immunobiology, 1993 - Elsevier
The work of immunologists, cell biologists and parasitologists in the field of leishmaniasis
has not only provided important insights into the immunopathogenesis of this disease, but …

[HTML][HTML] Unravelling the unsolved paradoxes of cytokine families in host resistance and susceptibility to Leishmania infection

BO Osero, RT Aruleba, F Brombacher, R Hurdayal - Cytokine: X, 2020 - Elsevier
Leishmaniasis is a neglected disease caused by protozoan parasites of the genus
Leishmania. Successful clearance of Leishmania relies on a robust human immune …

Pro-and anti-inflammatory cytokines in cutaneous leishmaniasis: a review

N Maspi, A Abdoli, F Ghaffarifar - Pathogens and global health, 2016 - Taylor & Francis
Cutaneous leishmaniasis (CL) is caused by different species of the genus Leishmania. Pro-
and anti-inflammatory cytokines play different roles in resistance/susceptibility and the …

Cytokines: key determinants of resistance or disease progression in visceral leishmaniasis: opportunities for novel diagnostics and immunotherapy

A Dayakar, S Chandrasekaran, SV Kuchipudi… - Frontiers in …, 2019 - frontiersin.org
Leishmaniasis is a parasitic disease of humans, highly prevalent in parts of the tropics,
subtropics, and southern Europe. The disease mainly occurs in three different clinical forms …

[HTML][HTML] Humoral immunity in leishmaniasis–Prevention or promotion of parasite growth?

R Goncalves, SM Christensen, DM Mosser - Cytokine: X, 2020 - Elsevier
Leishmaniasis can present as a “spectrum” of clinical outcomes. There is evidence that
these divergent clinical outcomes are attributable to genetic differences in the human host …

T-cell and cytokine responses in leishmaniasis

SG Reed, P Scott - Current opinion in immunology, 1993 - Elsevier
Intracellular pathogens, particularly those that inhabit lymphocytes and macrophages,
represent unique challenges to the immune system. Leishmania are protozoan parasites …

Role of cytokines in experimental and human visceral leishmaniasis

M Samant, U Sahu, SC Pandey… - Frontiers in cellular and …, 2021 - frontiersin.org
Visceral Leishmaniasis (VL) is the most fatal form of disease leishmaniasis. To date, there
are no effective prophylactic measures and therapeutics available against VL. Recently, new …